<- Go Home

Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, provides medicine packaging, drug delivery devices, and solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery devices, including inhalers, injection/auto injectors, and pen injectors. The company also provides diagnostic and medical devices comprising point-of-care tests, laboratory disposables, chemical and technical bottles, diagnostic and polymer vials, dropper bottles, PET bottles, and medical products comprising lancing devices, infusion sets, and disposable systems. In addition, it offers cosmetic packaging solutions, such as moulded glass flacons and jars; tubular glass ampoules, droppers, samplers and vials; and plastic packaging products, as well as pharmaceutical, laboratory, and regulatory affairs services. The company offers its products to pharmacy chains, supermarkets, and wholesalers. It serves pharma, biotech, medical technology, diagnostics, cosmetics, glass containers, and food and beverage industries. Gerresheimer AG was founded in 1864 and is based in Düsseldorf, Germany.

Market Cap

EUR 856.6M

Volume

214.5K

Cash and Equivalents

EUR 145.9M

EBITDA

EUR 385.0M

Tax Rate Collected

N/A

Tax Rate Ratio

N/A

Gross Profit

EUR 605.2M

Profit Margin

26.89%

52 Week High

EUR 85.25

52 Week Low

EUR 23.00

Dividend

0.16%

Price / Book Value

0.61

Price / Earnings

36.68

Price / Tangible Book Value

-2.77

Enterprise Value

EUR 3.0B

Enterprise Value / EBITDA

7.56

Operating Income

EUR 154.3M

Return on Equity

1.81%

Return on Assets

2.34

Cash and Short Term Investments

EUR 145.9M

Debt

EUR 2.3B

Equity

EUR 1.4B

Revenue

EUR 2.3B

Unlevered FCF

-EUR 499.9M

Sector

Life Sciences Tools and Services

Category

N/A

Hedge Funds that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Yellowbrick Portfolios that own this stock

PREMIUM

Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).

Upgrade to Yellowbrick Premium

Company Stock Pitches